Skip to main content
Log in

Complications associated with intra-arterial BCNU administered in combination with vincristine and procarbazine for the treatment of malignant brain tumors

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Summary

We have used intra-arterial (i.a.) 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) either alone or as part of adjuvant chemotherapy in patients with malignant brain tumors over a 3 year period (1979–1982). The i.a. BCNU technique was used 111 times to infuse 134 arteries in 37 patients. These patients, 28 cases with glial tumor and 9 cases with brain metastasis, received i.a. BCNU in combination with Vincristine and Procarbazine every 6 weeks. Complications encountered were transient and included: periorbital erythralgia or occipital-nuchal pain in 23 (62%), mild confusion and disorientation in 14 (38%), and ipsilateral conjunctival edema in 10 (27%). Reversible myelosuppression was not found. Our findings suggest that BCNU (100 Mg/M2) may be given by i.a. infusion in combination chemotherapy without persistent severe untoward effects with a cumulative dose of 700 mg/M2.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Klopp CT, Alford TC, Bateman J, Berry GN, Winship T: Fractionated regional cancer chemotherapy with methyl bis amine hydrochloride: A preliminary report. Annals of Surg 132:811–832, 1950.

    Google Scholar 

  2. French JD, West PM, Von Amerungen FK, MCGoun HW: Effects of intracarotid administration of nitrogen mustard on normal brain and brain tumors. J Neurosurg 9:378–389, 1952.

    Google Scholar 

  3. Owens G, Javid R, Tallon M, Stepanian G, Belmusto L: Arterial infusion chemotherapy of primary gliomas. A report of thirty cases. JAMA 186:802–803, 1963.

    Google Scholar 

  4. Watkins E Jr, Sullivan RD: Cancer chemotherapy by prolonged arterial infusion. Surg Gyn & Obst 118:3–19, 1964.

    Google Scholar 

  5. Mahaley MS Jr, Woodhall B: Regional chemotherapeutic perfusion and infusion of brain and face tumors. Annals of Surg 166:266–277, 1967.

    Google Scholar 

  6. Crafts DC, Levin VA, Nielsen S: Intracarotid BCNU (NSC409962): A toxicity study in six rhesus monkeys. Cancer Treat Rep 61:541–545, 1976.

    Google Scholar 

  7. Fenstermacher JD, Cowles AL: Theoretic limitations of intracarotid infusions in brain tumor chemotherapy. Cancer Treat Rep 61:519–526, 1977.

    Google Scholar 

  8. Levin VA, Kabra PM, Freeman-Dove MA: Pharmacokinetics of intracarotid artery 14C-BCNU in squirrel monkey. J Neurosurg 48:587–593, 1978.

    Google Scholar 

  9. Yamada K, Bremer AM, West CR, Ghoorah J, Park HC, Takita H: Intra-arterial BCNU therapy in the treatment of metastatic brain tumor from lung carcinoma. Cancer 44: 2000–2007, 1979.

    Google Scholar 

  10. Madajewicz S, West CR, park HC, Ghoorah J, Avellanosa AM, Takita H, Karakousis C, Vincent R, Caracandas J, Jennings E: Phase II study — Intra-arterial BCNU therapy for metastatic brain tumors. Cancer 47:653–657, 1981.

    Google Scholar 

  11. Greenberg HS, Ensminger WD, Seeger JF, Kindt GW, Chandler WF, Doan KM, Dakhil SR: Intra-arterial BCNU chemotherapy for the treatment of malignant gliomas of the central nervous system: A preliminary report. Cancer Treat Rep 65:803–810, 1981.

    Google Scholar 

  12. Grimson BS, Mahaley MS Jr, Dubey HD, Dudka L: Ophthalmic and central nervous system complications following intracarotid BCNU (Carmustine). J Clin Neuro-ophthalmol 1:261–264, 1981.

    Google Scholar 

  13. Kapp J, Vance R, Parker JL, Smith RR: Limitations of high dose intra-arterial 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) chemotherapy for malignant gliomas. Neurosurgery 10: 713–719, 1982.

    Google Scholar 

  14. Phillips TW, Chandler WF, Kindt GW, Ensminger WD, Greenberg HS, Seeger JF, Doan KM, Gyves JW: New implantable continuous administration and bolus dose intracarotid drug delivery system for the treatment of malignant gliomas. Neurosurgery 11:213–218, 1982.

    Google Scholar 

  15. Karnofsky DA, Burchenal JH: The clinical evaluation of chemotherapeutic agents in cancer. In: McLeod CM (ed) Evaluation of chemotherapeutic agents. Columbia University Press, New York, 1949, pp 191–205.

    Google Scholar 

  16. Kapp JP, Ross RL, Tucker EM: Supraophthalmic carotid infusion for brain-tumor chemotherapy. Technical note. J Neurosurg 58:616–618, 1983.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bremer, A.M., Kleriga, E., Nguyen, T.Q. et al. Complications associated with intra-arterial BCNU administered in combination with vincristine and procarbazine for the treatment of malignant brain tumors. J Neuro-Oncol 2, 129–132 (1984). https://doi.org/10.1007/BF00177898

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00177898

Keywords

Navigation